0001209191-21-070094.txt : 20211216 0001209191-21-070094.hdr.sgml : 20211216 20211216204742 ACCESSION NUMBER: 0001209191-21-070094 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211215 FILED AS OF DATE: 20211216 DATE AS OF CHANGE: 20211216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Randolph Sophia CENTRAL INDEX KEY: 0001817127 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39386 FILM NUMBER: 211499314 MAIL ADDRESS: STREET 1: C/O ALX ONCOLOGY HOLDINGS INC. STREET 2: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-15 0 0001810182 ALX ONCOLOGY HOLDINGS INC ALXO 0001817127 Randolph Sophia C/O ALX ONCOLOGY HOLDINGS INC. 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 1 1 0 0 Chief Medical Officer Common Stock 2021-12-15 4 M 0 12793 0.99 A 177337 D Common Stock 2021-12-15 4 M 0 11059 1.91 A 188396 D Stock Option (right to buy) 0.99 2021-12-15 4 M 0 12793 0.00 D 2027-03-30 Common Stock 12793 0 D Stock Option (right to buy) 1.91 2021-12-15 4 M 0 11059 0.00 D 2029-09-12 Common Stock 11059 12431 D Shares subject to the option are fully vested and immediately exercisable. The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020. /s/ Peter Garcia, by power of attorney 2021-12-16